Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

GelTex issued U.S. patent for cholesterol-reducing polymers

April 10, 1997

Ergoset enters clinical trials as adjunct therapy for type II diabetes

April 10, 1997

Lilly describes agents for postmenopausal syndrome

April 9, 1997

Chronic MK-677 increases GH and IGF-I in dogs

April 8, 1997

Cobalt porphyrins for obesity from Warner-Lambert

April 8, 1997

NO-1886 increases HDL cholesterol by increasing LPL activity

April 7, 1997

Nonoxynol-9 not effective for reducing HIV transmission

April 7, 1997

PPL Therapeutics produces salmon calcitonin in transgenic rabbits

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

Retinoids act as insulin sensitizers in mice

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...